Reports of Survivin expression in CNS tumours include two studies of gliomas and astrocytomas (Chakravarti et al, 2002; Kajiwara et al, 2003), and one study of mixed subtypes of CNS tumours (Sasaki et al, 2002). This evidence concerns the gene BIRC5 and central nervous system cancer.